Galmed Pharmaceuticals Ltd. (GLMD)
4.05
-0.26
(-5.92%)
USD |
NASDAQ |
Aug 24, 16:00
4.02
-0.03
(-0.74%)
After-Hours: 20:00
Galmed Pharmaceuticals Market Cap : 3.341M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.341M |
| August 21, 2026 | 3.552M |
| August 20, 2026 | 3.762M |
| August 19, 2026 | 3.935M |
| August 18, 2026 | 3.697M |
| August 17, 2026 | 3.388M |
| August 14, 2026 | 3.452M |
| August 13, 2026 | 28.04M |
| August 12, 2026 | 29.57M |
| August 11, 2026 | 29.40M |
| August 10, 2026 | 31.31M |
| August 07, 2026 | 31.78M |
| August 06, 2026 | 31.63M |
| August 05, 2026 | 30.62M |
| August 04, 2026 | 30.38M |
| August 03, 2026 | 30.89M |
| July 31, 2026 | 32.79M |
| July 30, 2026 | 31.63M |
| July 29, 2026 | 29.55M |
| July 28, 2026 | 28.19M |
| July 27, 2026 | 27.82M |
| July 24, 2026 | 27.08M |
| July 23, 2026 | 29.20M |
| July 22, 2026 | 26.66M |
| July 21, 2026 | 27.40M |
| Date | Value |
|---|---|
| July 20, 2026 | 27.17M |
| July 17, 2026 | 28.82M |
| July 16, 2026 | 29.04M |
| July 15, 2026 | 27.11M |
| July 14, 2026 | 27.00M |
| July 13, 2026 | 28.34M |
| July 10, 2026 | 29.57M |
| July 09, 2026 | 30.09M |
| July 08, 2026 | 30.09M |
| July 07, 2026 | 30.04M |
| July 06, 2026 | 29.41M |
| July 02, 2026 | 30.12M |
| July 01, 2026 | 34.20M |
| June 30, 2026 | 29.37M |
| June 29, 2026 | 30.14M |
| June 26, 2026 | 30.28M |
| June 25, 2026 | 30.28M |
| June 24, 2026 | 31.02M |
| June 23, 2026 | 30.20M |
| June 22, 2026 | 29.78M |
| June 18, 2026 | 30.62M |
| June 17, 2026 | 31.69M |
| June 16, 2026 | 31.91M |
| June 15, 2026 | 32.52M |
| June 12, 2026 | 32.31M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 13.05M |
| XTL Biopharmaceuticals Ltd. | 6.210M |
| Kamada Ltd. | 486.36M |
| Can-Fite BioPharma Ltd. | 4.390M |
| Revium Recovery, Inc. | 86.84M |
Market Cap Related Metrics
| Price to Book Value | 0.2396 |
| Price | 4.05 |
| Earnings Yield | -395.1% |